| PESUE20 | The effect of multi-month dispensing of ART on viral load suppression rates in 18 PEPFAR-supported countries | Poster exhibition | Differentiated service delivery for HIV testing, prevention and treatment |
| EPB023 | Global availability of skin biopsy for the diagnosis of Kaposi sarcoma in HIV treatment settings | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB024 | Evaluation of a rapid multiplex assay based digital screening strategy in Canada: what's the verdict? | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB025 | Syndemics in people newly diagnosed with HIV in Manitoba, Canada. Importance of coinfections and comorbidities | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB026 | Low utilization of TB-LAM for TB screening among children under five with advanced HIV disease in Uganda: a descriptive analysis of surveillance data | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB027 | Diagnostic performance of HbA1c, fasting blood glucose, and the oral glucose tolerance test among people with HIV | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB028 | Health related quality of life is impaired in people living with HIV and hepatic steatosis | E-poster | Diagnostics of co-infections and co-morbidities |
| EPB029 | Improved tuberculosis case finding among patients with Advanced HIV Disease in Nigeria through the deployment of a point of care tuberculosis diagnostic test | E-poster | Diagnostics of co-infections and co-morbidities |
| PESAB05 | Circulating mir21 and mir125b in women living with human immunodeficiency virus: utility of biomarkers for monitoring cervical carcinogenesis | Poster exhibition | Diagnostics of co-infections and co-morbidities |
| PESAB06 | Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with HIV-associated cryptococcosis | Poster exhibition | Diagnostics of co-infections and co-morbidities |